Global Monogenetic Disorders Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Monogenetic Disorders Testing Market Overview

• 1.1 Product Overview and Scope of Monogenetic Disorders Testing
• 1.2 Classification of Monogenetic Disorders Testing by Type
  • 1.2.1 Global Monogenetic Disorders Testing Revenue by Type: 2015 VS 2019 VS 2025
  • 1.2.2 Global Monogenetic Disorders Testing Revenue Market Share by Type in 2019
  • 1.2.3 Carrier Testing
  • 1.2.4 Diagnostic Testing
  • 1.2.5 New-Born Screening
  • 1.2.6 Predictive & Pre-Symptomatic Testing
  • 1.2.7 Prenatal Testing
  • 1.2.8 Others
• 1.3 Global Monogenetic Disorders Testing Market by Application
  • 1.3.1 Overview: Global Monogenetic Disorders Testing Revenue by Application: 2015 VS 2019 VS 2025
  • 1.3.2 Hospitals
  • 1.3.3 Specialized Clinics
  • 1.3.4 Ambulatory Surgical Centers
• 1.4 Global Monogenetic Disorders Testing Market by Regions
  • 1.4.1 Global Monogenetic Disorders Testing Market Size by Regions: 2015 VS 2019 VS 2025
  • 1.4.2 Global Market Size of Monogenetic Disorders Testing (2015-2025)
  • 1.4.3 North America (USA, Canada and Mexico) Monogenetic Disorders Testing Status and Prospect (2015-2025)
  • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Monogenetic Disorders Testing Status and Prospect (2015-2025)
  • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Monogenetic Disorders Testing Status and Prospect (2015-2025)
  • 1.4.6 South America (Brazil, Argentina, Colombia) Monogenetic Disorders Testing Status and Prospect (2015-2025)
  • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Monogenetic Disorders Testing Status and Prospect (2015-2025)

2 Company Profiles

• 2.1 Celera Group
  • 2.1.1 Celera Group Details
  • 2.1.2 Celera Group Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.1.3 Celera Group SWOT Analysis
  • 2.1.4 Celera Group Product and Services
  • 2.1.5 Celera Group Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.2 Roche
  • 2.2.1 Roche Details
  • 2.2.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.2.3 Roche SWOT Analysis
  • 2.2.4 Roche Product and Services
  • 2.2.5 Roche Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.3 ELITech Group
  • 2.3.1 ELITech Group Details
  • 2.3.2 ELITech Group Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.3.3 ELITech Group SWOT Analysis
  • 2.3.4 ELITech Group Product and Services
  • 2.3.5 ELITech Group Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.4 Abbott
  • 2.4.1 Abbott Details
  • 2.4.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.4.3 Abbott SWOT Analysis
  • 2.4.4 Abbott Product and Services
  • 2.4.5 Abbott Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.5 PerkinElmer
  • 2.5.1 PerkinElmer Details
  • 2.5.2 PerkinElmer Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.5.3 PerkinElmer SWOT Analysis
  • 2.5.4 PerkinElmer Product and Services
  • 2.5.5 PerkinElmer Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.6 Thermo Fisher Scientific
  • 2.6.1 Thermo Fisher Scientific Details
  • 2.6.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.6.3 Thermo Fisher Scientific SWOT Analysis
  • 2.6.4 Thermo Fisher Scientific Product and Services
  • 2.6.5 Thermo Fisher Scientific Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.7 Transgenomic
  • 2.7.1 Transgenomic Details
  • 2.7.2 Transgenomic Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.7.3 Transgenomic SWOT Analysis
  • 2.7.4 Transgenomic Product and Services
  • 2.7.5 Transgenomic Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.8 AutoGenomics
  • 2.8.1 AutoGenomics Details
  • 2.8.2 AutoGenomics Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.8.3 AutoGenomics SWOT Analysis
  • 2.8.4 AutoGenomics Product and Services
  • 2.8.5 AutoGenomics Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.9 Quest
  • 2.9.1 Quest Details
  • 2.9.2 Quest Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.9.3 Quest SWOT Analysis
  • 2.9.4 Quest Product and Services
  • 2.9.5 Quest Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)
• 2.10 Bio-Rad
  • 2.10.1 Bio-Rad Details
  • 2.10.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.10.3 Bio-Rad SWOT Analysis
  • 2.10.4 Bio-Rad Product and Services
  • 2.10.5 Bio-Rad Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

• 3.1 Global Monogenetic Disorders Testing Revenue and Share by Players (2015-2020)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Monogenetic Disorders Testing Players Market Share
  • 3.2.2 Top 10 Monogenetic Disorders Testing Players Market Share
• 3.3 Market Competition Trend

4 Market Size by Regions

• 4.1 Global Monogenetic Disorders Testing Revenue and Market Share by Regions
• 4.2 North America Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
• 4.3 Europe Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
• 4.4 Asia-Pacific Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
• 4.5 South America Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
• 4.6 Middle East & Africa Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)

5 North America Monogenetic Disorders Testing Revenue by Countries

• 5.1 North America Monogenetic Disorders Testing Revenue by Countries (2015-2020)
• 5.2 USA Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
• 5.3 Canada Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
• 5.4 Mexico Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)

6 Europe Monogenetic Disorders Testing Revenue by Countries

• 6.1 Europe Monogenetic Disorders Testing Revenue by Countries (2015-2020)
• 6.2 Germany Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
• 6.3 UK Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
• 6.4 France Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
• 6.5 Russia Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
• 6.6 Italy Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Monogenetic Disorders Testing Revenue by Countries

• 7.1 Asia-Pacific Monogenetic Disorders Testing Revenue by Countries (2015-2020)
• 7.2 China Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
• 7.3 Japan Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
• 7.4 Korea Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
• 7.5 India Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
• 7.6 Southeast Asia Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)

8 South America Monogenetic Disorders Testing Revenue by Countries

• 8.1 South America Monogenetic Disorders Testing Revenue by Countries (2015-2020)
• 8.2 Brazil Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
• 8.3 Argentina Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Monogenetic Disorders Testing by Countries

• 9.1 Middle East & Africa Monogenetic Disorders Testing Revenue by Countries (2015-2020)
• 9.2 Saudi Arabia Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
• 9.3 UAE Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
• 9.4 Egypt Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)
• 9.5 South Africa Monogenetic Disorders Testing Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

• 10.1 Global Monogenetic Disorders Testing Revenue and Market Share by Type (2015-2020)
• 10.2 Global Monogenetic Disorders Testing Market Forecast by Type (2019-2024)
• 10.3 Carrier Testing Revenue Growth Rate (2015-2025)
• 10.4 Diagnostic Testing Revenue Growth Rate (2015-2025)
• 10.5 New-Born Screening Revenue Growth Rate (2015-2025)
• 10.6 Predictive & Pre-Symptomatic Testing Revenue Growth Rate (2015-2025)
• 10.7 Prenatal Testing Revenue Growth Rate (2015-2025)
• 10.8 Others Revenue Growth Rate (2015-2025)

11 Global Monogenetic Disorders Testing Market Segment by Application

• 11.1 Global Monogenetic Disorders Testing Revenue Market Share by Application (2015-2020)
• 11.2 Monogenetic Disorders Testing Market Forecast by Application (2019-2024)
• 11.3 Hospitals Revenue Growth (2015-2020)
• 11.4 Specialized Clinics Revenue Growth (2015-2020)
• 11.5 Ambulatory Surgical Centers Revenue Growth (2015-2020)

12 Global Monogenetic Disorders Testing Market Size Forecast (2021-2025)

• 12.1 Global Monogenetic Disorders Testing Market Size Forecast (2021-2025)
• 12.2 Global Monogenetic Disorders Testing Market Forecast by Regions (2021-2025)
• 12.3 North America Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)
• 12.4 Europe Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)
• 12.5 Asia-Pacific Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)
• 12.6 South America Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)
• 12.7 Middle East & Africa Monogenetic Disorders Testing Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Data Source
• 14.3 Disclaimer